Ursina Teitelbaum

CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

Gregory L. Beatty, E. Gabriela Chiorean, Matthew P. Fishman et al. · Science · 2011 · 1.6K citations

Medicine, Immunology, Oncology +17

A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma

Gregory L. Beatty, Drew A. Torigian, E. Gabriela Chiorean et al. · Clinical Cancer Research · 2013 · 452 citations · Full text

Medicine, Oncology, Pharmacology +16

Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer

Thomas B. Karasic, Mark H. O’Hara, Arturo Loaiza‐Bonilla et al. · JAMA Oncology · 2019 · 290 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>

Kim A. Reiss, Rosemarie Mick, Mark H. O’Hara et al. · Journal of Clinical Oncology · 2021 · 239 citations

Medicine, Oncology, Pharmacology +14

Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial

Kim A. Reiss, Rosemarie Mick, Ursina Teitelbaum et al. · The Lancet Oncology · 2022 · 139 citations · Full text

Medicine, Oncology, Pharmacology +9